Sarepta’s Duchenne Gene Therapy Update Gets Bullish Stance From Analysts
Sarepta Therapeutics Inc (NASDAQ:SRPT) reported above-consensus 2Q FY22 product sales of $211 million and provided more details on the path forward…
Earnings Scheduled For August 2, 2022
Companies Reporting Before The Bell
• Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
Sarepta Therapeutics Earnings Preview
Sarepta Therapeutics (NASDAQ:SRPT) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement.
Analysts estimate that Sarepta Therapeutics will report an earnings per share (EPS) of $-1.18.
Chevron, Amazon And Some Other Big Gainers From Friday
U.S. stocks closed higher on Friday, with the Dow Jones jumping more than 300 points. Here is the list of some big stocks moving higher in the previous session.
Recap Of Friday’s Biotech Catalysts – End of The Day Summary
The U.S. Food and Drug Administration (FDA) has approved Arcutis Biotherapeutics’ (NASDAQ:ARQT) New Drug Application (NDA) for ZORYVE…
Duchenne Gene Therapy Firm Sarepta Therapeutics’ Earns 8% Price Target Hike From This Analyst
Earlier today, Sarepta Therapeutics Inc (NASDAQ:SRPT) announced that it would submit the marketing application and seek accelerated FDA approval for SRP-9001 in…
Needham Maintains Buy on Sarepta Therapeutics, Raises Price Target to $162
Needham analyst Gil Blum maintains Sarepta Therapeutics (NASDAQ:SRPT) with a Buy and raises the price target from $150 to $162.
Morgan Stanley Maintains Equal-Weight on Sarepta Therapeutics, Raises Price Target to $80
Morgan Stanley analyst Matthew Harrison maintains Sarepta Therapeutics (NASDAQ:SRPT) with a Equal-Weight and raises the price target from $74 to $80.
Avidity Biosciences Or Dyne Therapeutics – Read On Raymond James’ Rating Skew
Raymond James initiated coverage on Avidity Biosciences Inc (NASDAQ:RNA) with a Strong Buy rating and $29 price target (68% upside) and Dyne Therapeutics Inc (NASDAQ:DYN)…
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.